Publications

Search results

Journal Article (4)

  1. 1.
    Journal Article
    Bock, A.; Schulze-Horsel, J.; Schwarzer, J.; Rapp, E.; Genzel, Y.; Reichl, U.: High-density microcarrier cell cultures for influenza virus production. Biotechnology Progress 27 (1), pp. 241 - 250 (2011)
  2. 2.
    Journal Article
    Genzel, Y.; Dietzsch, C.; Rapp, E.; Schwarzer, J.; Reichl, U.: MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation. Applied Microbiology and Biotechnology 88 (2), pp. 461 - 475 (2010)
  3. 3.
    Journal Article
    Schwarzer, J.; Rapp, E.; Hennig, R.; Genzel, Y.; Jordan, I.; Sandig, V.; Reichl, U.: Glycan analysis in cell culture-based influenza vaccine production: Influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. Vaccine 27 (32), pp. 4325 - 4336 (2009)
  4. 4.
    Journal Article
    Schwarzer, J.; Rapp, E.; Reichl, U.: N-Glycan Analysis by CGE-LIF – Profiling Influenza A Virus Hemagglutinin N-Glycosylation during Vaccine Production. Electrophoresis 29 (20), pp. 4203 - 4214 (2008)

Conference Paper (2)

  1. 5.
    Conference Paper
    Roedig, J.; Rapp, E.; Hennig, R.; Schwarzer, J.; Reichl, U.: Optimized CGE-LIF-based glycan analysis for high-throughput applications. In: ESACT - Proceedings of the 21st Annual meeting of the European Society for animal cell technology (ESACT), pp. 599 - 603 (Eds. Jenkins, N.; Barron, N.; Alves, P.). 21st ESACT Meeting, Dublin, Ireland, June 07, 2009 - June 10, 2009. (2012)
  2. 6.
    Conference Paper
    Schwarzer, J.; Rapp, E.; Reichl, U.: Glycosylation of Influenza A Virus Hemagglutinin. In: Cells and Culture: Proceedings of the 20th ESACT Meeting, pp. 621 - 624 (Ed. Noll, T.). 20th ESACT Meeting, Dresden, Germany, June 17, 2007 - June 20, 2007. (2010)

Talk (12)

  1. 7.
    Talk
    Rödig, J.; Rapp, E.; Hütter, J.; Lepenies, B.; Schwarzer, J.; Genzel, Y.; Höper, D.; Reichl, U.: Impact of process conditions on influenza A virus HA N-glycosylation and immunogenicity. ProcessNet-Jahrestagung und 30. DECHEMA-Jahrestagung der Biotechnologen, Karlsruhe (2012)
  2. 8.
    Talk
    Rapp, E.; Hennig, R.; Roedig, J.; Schwarzer, J.; Reichl, U.: Glycosylation Pattern Analysis of Viral Antigens. 1st Workshop European Network on Viral Vaccine Processes (ENVVP), Dechema Haus, Frankfurt, Germany (2010)
  3. 9.
    Talk
    Rapp, E.; Schwarzer, J.; Hennig, R.; Genzel, Y.; Reichl, U.: Glycan-analysis in influenza vaccine production based on cgelif: influence of host cell and virus on the glycosylationpattern of viral hemagglutinin. EUROCARB 2009 (15th European Carbohydrate Symposium), Main University Vienna, Austria (2009)
  4. 10.
    Talk
    Rapp, E.; Schwarzer, J.; Hennig, R.; Roedig, J.; Reichl, U.: Towards High Throughput Characterization of Glycosylation-Patterns Using a Capillary-DNA-Sequencer. CE in Biotechnology & Pharmaceutical Industries: 11th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides and Small Molecules (CE Pharm 2009), Boston, MA, USA (2009)
  5. 11.
    Talk
    Rapp, E.; Schwarzer, J.; Reichl, U.: Characterization of the Influenza A Virus Hemagglutinin Glycosylation Pattern with Respect to Vaccine Production - Utilizing Capillary Gel Electrophoresis with Laser Induced Fluorescence Detection. 24th International Carbohydtrate Symposium (ICS), Oslo, Norway (2008)
  6. 12.
    Talk
    Rath, A.; Lohr, V.; Genzel, Y.; Schwarzer, J.; Rapp, E.; Sandig, V.; Jordan, I.; Reichl, U.: Influenza and modified vaccinia Ankara (MVA) production in avian designer cells. Bioperspectives, Hannover, Germany (2008)
  7. 13.
    Talk
    Genzel, Y.; Bock, A.; Schwarzer, J.; Dietzsch, C.; Reichl, U.: Implementation of analytical methods during upstream processing for an influenza A virus production process. Vaccine Production : Analytical Methods, Characterisation, Scale-up and Manufacturing, Cologne, Germany (2007)
  8. 14.
    Talk
    Rapp, E.; Schwarzer, J.; Reichl, U.: Characterisation of Glycosylation Patterns Utilizing a DNA-Sequenzer and a MALDI-TOF Mass Spectrometer. 7th Carbohydrate Bioengineering Meeting (CBM7), Braunschweig, Germany (2007)
  9. 15.
    Talk
    Rapp, E.; Schwarzer, J.; Reichl, U.: Elucidation of the Influenza A Virus Glycosylation Patterns with Respect to Vaccine Production Down to the Lower Zeptomolar Range. 21st International Symposium on MicroScale Bioseparations (MSB), Vancouver, BC, Canada (2007)
  10. 16.
    Talk
    Rapp, E.; Schwarzer, J.; Reichl, U.: Characterisation of Glycosylation Patterns Utilizing a DNA-Sequenzer and Mass Spectrometry. 14th European Carbohydrate Symposium, Lübeck, Germany (2007)
  11. 17.
    Talk
    Schwarzer, J.; Rapp, E.; Reichl, U.: N-glycan analysis method for cell culture derived influenza virus hemagglutinin. Joint Meeting 2007, Lille, France (2007)
  12. 18.
    Talk
    Wolff, M. W.; Salaklang, J.; Opitz, L.; Schwarzer, J.; Rapp, E.; Kalbfuss, B.; Reichl, U.: Development of a lectin-affinity chromatography step for the downstream processing of influenza virus vaccines. AICHE Annual Meeting 2005, Cincinnati, Ohio, USA (2005)

Poster (14)

  1. 19.
    Poster
    Roedig, J.; Rapp, E.; Hennig, R.; Schwarzer, J.; Reichl, U.: Optimized CGE-LIF-based glycan analysis for high-throughput applications. 21st ESACT Meeting, Dublin, Ireland (2009)
  2. 20.
    Poster
    Roedig, J.; Rapp, E.; Schwarzer, J.; Genzel, Y.; Reichl, U.: Impact of viral adaption on the N-glycosylation pattern of Influenza A hemagglutinin. ProcessNet-Jahrestagung 2009 und die 27.Jahrestagung der Biotechnologen , Mannheim, Germany (2009)
 
loading content
Go to Editor View